Clinical Research Directory

Inclusion Criteria: * Patients with a definite diagnosis of malignancy by histopathology and/or cytology; * Age ≥18 years; * There is no gender limit * Plan to receive antineoplastic therapy within 2 weeks or are receiving standard antineoplastic care (surgery, radiation, chemotherapy, or targeted therapy) ; * Conscious and able to answer questions and use electronic devices autonomously; * Patients were able to understand the study and voluntarily sign an informed consent form; Exclusion Criteria: * Having severe mental or cognitive impairments that prevent them from understanding the content of the study or implementing the programme; * With severe heart disease, acute respiratory failure, liver kidney failure and other critical illness; * Women during pregnancy or lactation； * Have participated in other interventional studies in the past 1 month or are currently participating; * Patients with ECOG ≥ 3 that do not respond to treatment; * Patients with an expected survival of \< 3 months that do not respond to treatment; * Cases deemed unsuitable for enrollment by the investigator.